Importantly, in our studies, the Gfap-tk mice did not experience any detectable small intestinal hemorrhaging and were able to survive the entire AOM/DSS regimen (around nine weeks) while undergoing continuous ganciclovir treatment. This evidence concerns the gene GFAP and infectious otitis media.